A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Public ClinicalTrials.gov record NCT06024746. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Combined Efficacy and Safety of an Early, Intensive, Management Strategy With Finerenone and SGLT2 Inhibitor in Patients Hospitalized With Heart Failure (CONFIRMATION-HF)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Combination therapy of finerenone plus empagliflozin will be compared to usual care to determine the efficacy and safety of treatment in patients hospitalized with heart failure.
Study identification
- NCT ID
- NCT06024746
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,500 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 8, 2024
- Primary completion
- Oct 31, 2027
- Completion
- Oct 31, 2027
- Last update posted
- Jul 22, 2026
2024 – 2027
United States locations
- U.S. sites
- 33
- U.S. states
- 17
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| CON-10004 Fairhope, AL Investigational Site | Fairhope | Alabama | 36532 | Recruiting |
| CON-10075 El Centro, CA Investigational Site | El Centro | California | 92243 | Recruiting |
| CON-10024 Sacramento, CA Investigational Site | Sacramento | California | 95816 | Recruiting |
| CON-10023, San Francisco, CA | San Francisco | California | 94118 | Recruiting |
| CON-10109, Van Nuys, CA | Van Nuys | California | 91405 | Recruiting |
| CON-10001, Aurora, CO | Aurora | Colorado | 80045 | Recruiting |
| CON-10005, Denver, CO | Denver | Colorado | 80204 | Recruiting |
| CON-10078, Hialeah, FL | Hialeah | Florida | 33012 | Recruiting |
| CON-10105, Miami, FL | Miami | Florida | 33135 | Recruiting |
| CON-10113, Miramar, FL | Miramar | Florida | 33027 | Recruiting |
| CON-10022 Atlanta, GA Investigational Site | Atlanta | Georgia | 30303 | Recruiting |
| CON-10021, Glenview, IL | Glenview | Illinois | 60026 | Recruiting |
| CON-10041, Island Lake, IL | Island Lake | Illinois | 60042 | Recruiting |
| CON-10025, Naperville, IL | Naperville | Illinois | 60540 | Recruiting |
| CON-10019, Peoria, IL | Peoria | Illinois | 61603 | Recruiting |
| CON-10064, Merrillville, IN | Merrillville | Indiana | 46410 | Recruiting |
| CON-10080, Lexington, KY | Lexington | Kentucky | 40503 | Recruiting |
| CON-10086, Louisville, Kentucky | Louisville | Kentucky | 40205 | Recruiting |
| CON-10079, Paducah, KY | Paducah | Kentucky | 42003 | Recruiting |
| CON-10030 Baton Rouge, LA Investigational Site | Baton Rouge | Louisiana | 70808 | Recruiting |
| CON-10090, West Monroe, LA | West Monroe | Louisiana | 71291 | Recruiting |
| CON-10002 Kansas City, MO Investigative Site | Kansas City | Missouri | 64111 | Recruiting |
| CON-10018, Omaha, NE | Omaha | Nebraska | 68105 | Recruiting |
| CON-10318, Charlotte, NC | Charlotte | North Carolina | 28207 | Recruiting |
| CON-10119, Centerville, OH | Centerville | Ohio | 45459 | Recruiting |
| CON-10051, Chattanooga, TN | Chattanooga | Tennessee | 37403 | Recruiting |
| CON-10045 Amarillo, TX Investigational Site | Amarillo | Texas | 79106 | Recruiting |
| CON-10015 Austin, TX Investigational Site | Austin | Texas | 78705 | Recruiting |
| CON-10304, Denison, TX | Denison | Texas | 75020 | Recruiting |
| CON-10301, Fort Worth, TX | Fort Worth | Texas | 76104 | Recruiting |
| CON-10085, Houston, TX | Houston | Texas | 77030 | Recruiting |
| CON-10305, Layton, UT | Layton | Utah | 84041 | Recruiting |
| CON-10009, Norfolk, VA | Norfolk | Virginia | 23507 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 71 non-U.S. sites.
Recently updated Heart Failure trials
Other public records listing Heart Failure. Sorted by last update posted; newest first. Not a recommendation.
- NCT07794930: Integrating Values Based Communication in Heart Failure Management Not yet recruiting
- NCT05585125: A Preliminary Study for INFORMED Recruiting
- NCT07232030: Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure Recruiting
- NCT07771231: Kosmos PLAX EF Pivotal Study Active, not recruiting
- NCT06812533: Alleviant ALLAY-HFrEF Study Recruiting
- NCT05685303: Alleviant ALLAY-HF Study Recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06024746, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 22, 2026 · Synced Jul 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06024746 live on ClinicalTrials.gov.